CURE Logo.png
CURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate Development
May 09, 2017 09:00 ET | CURE Pharmaceutical
OXNARD, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching cannabinoid molecules for various...
CURE Logo.png
CURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of Directors
May 03, 2017 09:00 ET | CURE Pharmaceutical
OXNARD, Calif., May 03, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching cannabinoid molecules for various...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Receives Schedule 1 Permit to Move Forward With Development of MedChew Rx Pharmaceutical Chewing Gum
May 02, 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, May 02, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company’s product...
NFL Legend Tackles Chronic Traumatic Encephalopathy (CTE) with help from Cannabidiol (CBD)
April 13, 2017 09:30 ET | Elixinol
DENVER, April 13, 2017 (GLOBE NEWSWIRE) -- Super Bowl champion Leonard Marshall has renewed vigor since he stopped taking synthetic prescription drugs for CTE and started taking organic cannabidiol...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Advisory Board Member Presented at CannMed 2017 Personalized Cannabinoid Medicine Conference at Harvard
April 13, 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, April 13, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that Dr. Ilya Reznik, a...
PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest Pty Limited
April 13, 2017 09:00 ET | PreveCeutical Medical Inc
VANCOUVER, British Columbia, April 13, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilizing nature and science for the benefit of...
IGC Files Patent for Cannabis-based Combination Therapy for Treatment of Eating Disorders
March 21, 2017 08:00 ET | India Globalization Capital
BETHESDA, Md., March 21, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) today announces its provisional patent filing (IGC-506) for the treatment of multiple types of...
IGC Announces Third Quarter Financial Results
February 21, 2017 18:13 ET | India Globalization Capital
BETHESDA, Md., Feb. 21, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE MKT:IGC) announced financial results for the third quarter ended December 31, 2016 for the fiscal year...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech to Attend the 19th Annual BIO CEO & Investor Conference in New York
February 09, 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, Feb. 09, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E. Anastassov,...
AXIM® Biotech Expands Advisory Board to Broaden the Development of Cannabinoids' Therapeutic Indications
December 29, 2016 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, Dec. 29, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in biotechnology cannabinoid research and development, announced today the addition...